Clinical trial
Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEG
NCT00464451 · Wesley Medical Center, Other · Withdrawn
Key facts
| NCT number | NCT00464451 |
|---|---|
| Title | Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEG |
| Official title | Prospective, Double Blinded,Randomized Controlled Trial of Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEG |
| Lead sponsor | Wesley Medical Center, Other |
| Collaborators | Hospira, now a wholly owned subsidiary of Pfizer Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Procedural Sedation |
| Intervention type | Drug |
| Interventions | Dexmedetomidine, Chloral hydrate |
| Enrollment | 0 |
| Start date | Aug 1, 2009 |
| Primary completion | Dec 1, 2010 |
| Completion | May 1, 2011 |
| First posted | Apr 23, 2007 |
| Last update posted | Nov 3, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: